MADELINE ANTILL: Open Payments
NPI 1982161287 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Lilly USA, LLC | 3 | $64 |
| Abbott Laboratories | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
Products named: CAPLYTA, Kerendia, JARDIANCE, FREESTYLE LIBRE 3, XIFAXAN, VRAYLAR, Cologuard Collection Kit, MOUNJARO.
Industry payments across OH — which companies pay providers there.
